PODXL
PODXL (podocalyxin like), also known as PCLP, Gp200, PC, PODXL1, PDX and gp135, is a sialomucin that regulates cell adhesion and morphology. It was first identified as a major component of glomerular podocytes and is also linked to cancer progression. Browse Assay Genie's current range of PODXL research reagents below, or read on for the biology behind the target.
PODXL is involved in the regulation of adhesion, cell morphology and cancer progression. In podocytes it acts as an anti-adhesive molecule, maintaining an open filtration pathway between neighbouring foot processes by charge repulsion. In other settings it behaves as a pro-adhesive molecule, enhancing the adherence of cells to immobilised ligands and increasing the rate of migration and cell-cell contacts in an integrin-dependent manner.
The protein also induces the formation of apical actin-dependent microvilli. It contributes to a preapical plasma membrane subdomain that sets up initial epithelial polarisation and apical lumen formation during renal tubulogenesis. UniProt records its localisation to the apical cell membrane, membrane rafts and several cell projections, including lamellipodia, filopodia, ruffles and microvilli. In a membrane protein complex it binds Na+/H+ exchanger regulatory factor, which links it to intracellular cytoskeletal elements.
The PODXL gene encodes a member of the podocalyxin family of sialomucins. Podocytes are highly differentiated epithelial cells whose interdigitating foot processes cover the outer aspect of the glomerular basement membrane. Beyond the kidney, PODXL is expressed in vascular endothelial cells, binds L-selectin and plays a role in haematopoietic cell differentiation. In cancer, it promotes migration and invasion through its interaction with the actin-binding protein EZR, which increases MAPK and PI3K pathway activity. The mouse and rat orthologues are both named Podxl.
PODXL is a key component of glomerular podocytes, where its charge repulsion keeps the filtration pathway open between foot processes.
PODXL promotes cell migration and invasion through EZR, raising MAPK and PI3K pathway activity in cancer cells.
PODXL helps establish a preapical membrane subdomain and apical microvilli, supporting epithelial polarisation and lumen formation in renal tubulogenesis.
PODXL is expressed in vascular endothelium, binds L-selectin and contributes to haematopoietic cell differentiation.
PODXL regulates cell adhesion and morphology. It is anti-adhesive in podocytes, keeping the filtration pathway open by charge repulsion, and pro-adhesive elsewhere, enhancing integrin-dependent adherence and migration. It also induces apical microvilli and supports epithelial polarisation and lumen formation.
PODXL stands for podocalyxin like, and the protein is called podocalyxin. Aliases include PCLP, Gp200, PC, PODXL1, PDX and gp135. The previous HGNC name was podocalyxin-like. Check the datasheet of any product for its validated reactivity.
UniProt reports that PODXL plays a role in cancer development and aggressiveness. It induces cell migration and invasion by interacting with the actin-binding protein EZR, which increases MAPK and PI3K pathway activity in cancer cells. Mouse and rat orthologues are both called Podxl.
Binding partners, podocyte markers and adhesion-related targets connected to PODXL biology.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O00592; product specifications from Assay Genie datasheets.